TD SYNNEX CORP
SNXNYSE🏆 #556 by market capEarnings Jan 6 · PreUS Equity
$259.14▲ $2.41 (+0.93%)
LiveTrack SNX
Get earnings, price moves & breaking news on Telegram
24h▲ 0.9%
7d▼ 8.5%
14d▼ 1.3%
30d▲ 2.0%
ytd▲ 72.6%
1y▲ 56.1%
🏦Market Cap
$20.72B
Mid Cap
📈Revenue Growth (YoY)
+6.9%
Slowing
📊Gross Margin
6.8%
Thin
💵FCF Margin
-1.1%
Thin
⚖️P/S Ratio
0.3x
Cheap
Otter Score
88
Very Good
TD SYNNEX CORP
SNXAnalyst Ratings
Price
$259.14
Total
24
Raised
3
Lowered
1
Avg PT
$336.67
H / L
$379 / $287
| Institution | Action | Rating | Date | Upside | |
|---|---|---|---|---|---|
UBS | Reiterated | Buy | 2026-09-25 | $379.00 | +46.30% |
Morgan Stanley | Reiterated | Overweight | 2026-09-25 | $359.00 | +38.50% |
Barclays | Reiterated | Equal Weight | 2026-09-08 | $287.00 | +10.80% |
Barrington Research | Reiterated | Outperform | 2026-06-26 | — | — |
Goldman Sachs | Reiterated | Buy | 2026-06-12 | $330.00 | +27.30% |
RBC Capital | Reiterated | Outperform | 2026-06-10 | $340.00 | +31.20% |
JP Morgan | Upgraded | Neutral → Overweight | 2026-05-27 | — | — |
B of A Securities | Reiterated | Buy | 2025-09-26 | — | — |
Loop Capital | Reiterated | Buy | 2025-06-30 | — | — |
CFRA | Reiterated | Buy | 2025-03-28 | — | — |
Stifel | Reiterated | Buy | 2023-09-19 | — | — |
Credit Suisse | Reiterated | Neutral | 2023-06-28 | — | — |
Raymond James | Reiterated | Strong Buy | 2023-06-28 | $175.00 | −32.50% |
Citigroup | Reiterated | Buy | 2022-06-29 | — | — |
Cross Research | Upgraded | Hold → Buy | 2022-01-12 | — | — |
Stifel Nicolaus | Reiterated | Buy | 2018-10-04 | $130.00 | −49.80% |
Pivotal Research | Upgraded | Hold → Buy | 2018-01-31 | — | — |
CLSA | Reiterated | Underperform | 2016-09-27 | — | — |
Brean Capital | Reiterated | Buy | 2016-06-24 | — | — |
Macquarie | Reiterated | Outperform | 2016-01-11 | — | — |
Needham | Downgraded | Buy → Hold | 2015-06-26 | — | — |
Bank of America | Reiterated | Buy | 2013-08-28 | — | — |
Credit Agricole | Reiterated | Buy → Outperform | 2013-03-28 | — | — |
Sterne Agee | Reiterated | Neutral | 2012-09-26 | — | — |
Institution
UBS
Reiterated · Buy · 2026-09-25
$379.00
+46.30%
Morgan Stanley
Reiterated · Overweight · 2026-09-25
$359.00
+38.50%
Barclays
Reiterated · Equal Weight · 2026-09-08
$287.00
+10.80%
Barrington Research
Reiterated · Outperform · 2026-06-26
—
—
Goldman Sachs
Reiterated · Buy · 2026-06-12
$330.00
+27.30%
RBC Capital
Reiterated · Outperform · 2026-06-10
$340.00
+31.20%
JP Morgan
Upgraded · Neutral → Overweight · 2026-05-27
—
—
B of A Securities
Reiterated · Buy · 2025-09-26
—
—
Loop Capital
Reiterated · Buy · 2025-06-30
—
—
CFRA
Reiterated · Buy · 2025-03-28
—
—
Stifel
Reiterated · Buy · 2023-09-19
—
—
Credit Suisse
Reiterated · Neutral · 2023-06-28
—
—
Raymond James
Reiterated · Strong Buy · 2023-06-28
$175.00
−32.50%
Citigroup
Reiterated · Buy · 2022-06-29
—
—
Cross Research
Upgraded · Hold → Buy · 2022-01-12
—
—
Stifel Nicolaus
Reiterated · Buy · 2018-10-04
$130.00
−49.80%
Pivotal Research
Upgraded · Hold → Buy · 2018-01-31
—
—
CLSA
Reiterated · Underperform · 2016-09-27
—
—
Brean Capital
Reiterated · Buy · 2016-06-24
—
—
Macquarie
Reiterated · Outperform · 2016-01-11
—
—
Needham
Downgraded · Buy → Hold · 2015-06-26
—
—
Bank of America
Reiterated · Buy · 2013-08-28
—
—
Credit Agricole
Reiterated · Buy → Outperform · 2013-03-28
—
—
Sterne Agee
Reiterated · Neutral · 2012-09-26
—
—
One row per institution · price target from the firm's latest published target
StockOtter · stockotter.space